| PERIOD ENDING | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | 31-Oct-08 | | Total Revenue | 126 | 142 | 257 | 133 | | Cost of Revenue | 64 | 60 | 208 | (33) | | | Gross Profit | 62 | 82 | 50 | 166 | | | Operating Expenses | | Research Development | 125 | 83 |
-
| 1,056 | | Selling General and Administrative | 109 | 70 | 280 | 123 | | Non Recurring | 45 | (9) |
-
| 1,792 | | Others |
-
|
-
|
-
| 37 | | | | Total Operating Expenses |
-
|
-
|
-
| 3,008 | | | | Operating Income or Loss | (217) | (62) | (230) | (2,842) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (217) | (62) | (230) | (2,842) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (217) | (62) | (230) | (2,842) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (217) | (62) | (230) | (2,842) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (217) | (62) | (230) | (2,842) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($217) | ($62) | ($230) | ($2,842) |
|
0.01% Nasdaq 
0.74%
Income Statement
